Running News and Research

RSS

First Edition: May 3, 2010

Today's headlines include analysis of how this year's health reform debate is shaping other national policy initiatives and the upcoming mid-term elections.

3 May 2010

Report highlights lack of humanitarian access to Cyclone Nargis survivors in Myanmar

"Almost two years after Cyclone Nargis killed nearly 140,000 people in Myanmar, the repression of rights in areas hit by the cyclone continues and the humanitarian space in the country is shrinking instead of growing as originally hoped, a [Human Rights Watch] report released on Thursday said," Reuters AlertNet reports.

3 May 2010

Some Republican states opting out of high risk health insurance pools

News outlets covered state responses to the federal government's deadline on high risk insurance pools.

3 May 2010

FDA oks 'vaccine' to treat prostate cancer

Provenge, developed by Dendreon Corporation, is the first approved "treatment that uses a so-called cancer vaccine, a drug that trains the body's own immune system to fight the disease," The New York Times reports.

3 May 2010

Boston hospital program prepares doctors for emergency medical situations

WBUR/NPR reports on a hospital program that replicates the scenario in Haiti to better prepare doctors for emergency medical situations.

3 May 2010

Exercise tips for long-term fitness

From working out to eating right, knowing how to best live a healthy lifestyle can become confusing. The long-term health landscape continues to change as research into integrative medicine and genomic function evolves.

3 May 2010

Winner Medical Group closes public offering of 1,380,000 shares of common stock

Winner Medical Group Inc., a leading manufacturer of medical dressings, medical disposables and non-woven PurCotton materials for the medical and consumer products industries, announced today that it closed its previously announced public offering of 1,380,000 shares of common stock.

3 May 2010

First Edition: April 30, 2010

Today's headlines focus on state decisions regarding new health insurance pools; insurers' plans regarding the early adoption of some reform law provisions; and, of course, the politics that continue to surround health reform.

30 Apr 2010

Self-sealing sleeve for wound protection

As the days get longer and temperatures rise, so do incidences of outdoor-related injuries.

30 Apr 2010

Reliv International's first-quarter 2010 net sales decline 4.5%

Reliv International, Inc., a nutrition and direct selling company, today reported that sales and earnings in the first-quarter of 2010 were below last year's first-quarter results, but sales outside of the United States rose during the period.

30 Apr 2010

Study uncovers transcription control mechanism that is regulated by cancer-causing gene

A comprehensive new gene expression study in embryonic stem cells has uncovered a transcription control mechanism that is not only more pervasive than once thought but is also heavily regulated by the cancer-causing gene c-Myc.

30 Apr 2010

A major research initiative to optimize quality of life for cancer survivors

At the age of 12, she was diagnosed with spinal cord cancer, with a nasty tumor sitting at the very base of her spinal cord and getting entangled with spinal nerves.

30 Apr 2010

Researchers identify key protein that regulates innate immune system

A team of researchers led by Baylor College of Medicine has identified a protein called NLRC5, a member of the NOD-like protein family, that is involved in inhibition of protein complexes key to critical pathways of innate immunity called NF-κB and type I interferon signaling. A report on their work appears in the current issue of the journal Cell.

30 Apr 2010

Pain Therapeutics reports net loss of $1.0 million for first-quarter 2010

Pain Therapeutics, Inc., a biopharmaceutical company, today reported first quarter 2010 financial results. Net loss for Q1 2010 was $1.0 million, or $0.02 per share, compared to a net loss of $1.8 million, or $0.04 per share, for Q1 2009.

29 Apr 2010

Neurocrine Biosciences reports net loss of $8.6M in first quarter 2010

Neurocrine Biosciences, Inc. today announced its financial results for the quarter ended March 31, 2010. For the first quarter of 2010, the Company reported a net loss of $8.6 million, or $0.19 per share compared with a net loss of $19.7 million, or $0.51 per share, for the same period in 2009.

29 Apr 2010

State Round-up: Federal prosecutors investigate bid rigging at New York hospitals; Montana prepares for health reform implementation; and Florida spares Medicaid from budget cuts

The Wall Street Journal: "Federal prosecutors are investigating allegations that bid rigging and fraud at Mount Sinai Medical Center and New York-Presbyterian Hospital resulted in the hospitals awarding contracts worth tens of millions of dollars to outside contractors. Purchasing officials at the hospitals ... are alleged to have gotten more than a million dollars in payments from companies that were then given lucrative contracts to perform work such as re-insulating pipes and removing asbestos, according to documents filed in the Southern District of New York.

28 Apr 2010

Report looks at AIDS funding in developing countries

"A global pullback on commitments to fund and fight AIDS is resulting in restrictions on the number of people being enrolled into treatment programmes, more frequent drug shortages, and reduced national AIDS budgets," according to a report released Monday by the International Treatment Preparedness Coalition, BMJ News reports.

28 Apr 2010

Nile Therapeutics closes underwritten public offering of common stock

Nile Therapeutics, Inc., a company focused on the development of novel therapeutics for heart failure patients, announced the closing of its previously announced underwritten public offering of 6,500,000 units of its securities consisting of an aggregate of 6,500,000 shares of common stock and warrants to purchase an aggregate of 1,950,000 shares of common stock.

28 Apr 2010

Southwest Bancorp prices underwritten public offering of 4,000,000 common stock shares at $12.50 per share

Southwest Bancorp, Inc., today announced that it has priced its underwritten public offering of 4,000,000 shares of common stock at a price to the public of $12.50 per share for net proceeds of approximately $47.0 million. The offering was increased from the previously announced offering size of approximately $40 million. The offering is expected to close on April 29, 2010.

27 Apr 2010

Cell phone program to promote more physical activity

About two thirds of the American population is overweight or obese, putting them at higher risk for health problems such as heart disease, stroke, cancer and diabetes. The obesity epidemic in America is the result of poor eating habits, genetics, and a lack of exercise. It's therefore difficult for public health officials to get people to make a conscious effort to control their weight.

27 Apr 2010